Skip to main content
Erschienen in: Journal of Nephrology 6/2015

01.12.2015 | Original Article

Diagnostic value of quantitative contrast-enhanced ultrasound (CEUS) for early detection of renal hyperperfusion in diabetic kidney disease

verfasst von: Ling Wang, Jian Wu, Jia-Fen Cheng, Xin-Ying Liu, Fang Ma, Le-Hang Guo, Jun-Mei Xu, Tianfu Wu, Chandra Mohan, Ai Peng, Hui-Xiong Xu, Ya-Xiang Song

Erschienen in: Journal of Nephrology | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the diagnostic value of quantitative contrast-enhanced ultrasound (CEUS) for early detection of renal hyperperfusion in diabetic kidney disease (DKD).

Materials and methods

55 DKD patients with estimated glomerular filtration rate (eGFR) >30 ml/min/1.73 m2 and 26 normal controls (NCs) were enrolled. Clinical data was well documented. Blood samples were drawn for evaluation of renal function including blood urea nitrogen (BUN), serum creatinine (SCr) and serum uric acid (SUA), and urine samples were assayed for total protein quantification, and various microprotein markers. According to eGFR level, DKD patients were divided into early-stage DKD (eGFR ≥90 ml/min/1.73 m2, n = 18) and middle-stage DKD (eGFR 30–90 ml/min/1.73 m2, n = 37). Based on urinary microalbumin/creatinine ratio (MALB/UCR), early-stage DKD patients were further classified into two groups: MALB/UCR <10 g/mol (n = 11) and MALB/UCR ≥10 g/mol (n = 7). Then, CEUS was performed to observe the real-time renal perfusion, and low acoustic power contrast-specific imaging was used for quantitative analysis.

Results

The renal perfusion images of CEUS were well developed successively. The corresponding perfusion curves based on echo-power signals in time series were constructed. Quantitative analysis showed that area under the descending curve (AUC2) was significantly increased in early-stage DKD compared to middle-stage DKD (p < 0.05), but AUC showed no significant difference. Further comparison between different MALB/UCR levels of early-stage DKD showed that patients with MALB/UCR ≥10 g/mol had significantly increased levels of AUC, AUC2 and proteinuria than patients with low MALB/UCR (p < 0.05). Also, high MALB/UCR DKD patients had increased proteinuria but similar eGFR compared to low MALB/UCR patients.

Conclusion

Renal microvascular hyperperfusion may be responsible for overt proteinuria until decline of renal filtration in DKD. AUC2 could be an early and sensitive marker for early renal injury and renal microvascular hyperperfusion in DKD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Agarwal R, Duffin KL, Laska DA, Voelker JR, Breyer MD, Mitchell PG (2014) A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease. Nephrol Dial Transplant. doi:10.1093/ndt/gfu255 PubMedCentral Agarwal R, Duffin KL, Laska DA, Voelker JR, Breyer MD, Mitchell PG (2014) A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease. Nephrol Dial Transplant. doi:10.​1093/​ndt/​gfu255 PubMedCentral
3.
Zurück zum Zitat Hughson MD, Johnson K, Young RJ, Hoy WE, Bertram JF (2002) Glomerular size and glomerulosclerosis: relationships to disease categories, glomerular solidification, and ischemic obsolescence. Am J Kidney Dis 39:679–688. doi:10.1053/ajkd.2002.31980 CrossRefPubMed Hughson MD, Johnson K, Young RJ, Hoy WE, Bertram JF (2002) Glomerular size and glomerulosclerosis: relationships to disease categories, glomerular solidification, and ischemic obsolescence. Am J Kidney Dis 39:679–688. doi:10.​1053/​ajkd.​2002.​31980 CrossRefPubMed
6.
Zurück zum Zitat Baykal-Erkilic A, Erkilic M, Ozben T (1995) The effects of streptozocin-induced diabetes on renal plasma flow. Exp Clin Endocrinol Diabetes 103:367–372CrossRefPubMed Baykal-Erkilic A, Erkilic M, Ozben T (1995) The effects of streptozocin-induced diabetes on renal plasma flow. Exp Clin Endocrinol Diabetes 103:367–372CrossRefPubMed
7.
Zurück zum Zitat Tuttle KR, Bruton JL (1992) Effect of insulin therapy on renal hemodynamic response to amino acids and renal hypertrophy in non-insulin-dependent diabetes. Kidney Int 42:167–173CrossRefPubMed Tuttle KR, Bruton JL (1992) Effect of insulin therapy on renal hemodynamic response to amino acids and renal hypertrophy in non-insulin-dependent diabetes. Kidney Int 42:167–173CrossRefPubMed
8.
Zurück zum Zitat Wentland AL, Artz NS, Fain SB, Grist TM, Djamali A, Sadowski EA (2012) MR measures of renal perfusion, oxygen bioavailability and total renal blood flow in a porcine model: noninvasive regional assessment of renal function. Nephrol Dial Transplant 27:128–135. doi:10.1093/ndt/gfr199 PubMedCentralCrossRefPubMed Wentland AL, Artz NS, Fain SB, Grist TM, Djamali A, Sadowski EA (2012) MR measures of renal perfusion, oxygen bioavailability and total renal blood flow in a porcine model: noninvasive regional assessment of renal function. Nephrol Dial Transplant 27:128–135. doi:10.​1093/​ndt/​gfr199 PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Chowdhury AH, Cox EF, Francis ST, Lobo DN (2014) A randomized, controlled, double-blind crossover study on the effects of 1-L infusions of 6% hydroxyethyl starch suspended in 0.9% saline (voluven) and a balanced solution (Plasma Volume Redibag) on blood volume, renal blood flow velocity, and renal cortical tissue perfusion in healthy volunteers. Ann Surg 259:881–887. doi:10.1097/SLA.0000000000000324 CrossRefPubMed Chowdhury AH, Cox EF, Francis ST, Lobo DN (2014) A randomized, controlled, double-blind crossover study on the effects of 1-L infusions of 6% hydroxyethyl starch suspended in 0.9% saline (voluven) and a balanced solution (Plasma Volume Redibag) on blood volume, renal blood flow velocity, and renal cortical tissue perfusion in healthy volunteers. Ann Surg 259:881–887. doi:10.​1097/​SLA.​0000000000000324​ CrossRefPubMed
10.
Zurück zum Zitat Lim SW, Chrysochou C, Buckley DL, Kalra PA, Sourbron SP (2013) Prediction and assessment of responses to renal artery revascularization with dynamic contrast-enhanced magnetic resonance imaging: a pilot study. Am J Physiol Renal Physiol 305:F672–F678. doi:10.1152/ajprenal.00007.2013 CrossRefPubMed Lim SW, Chrysochou C, Buckley DL, Kalra PA, Sourbron SP (2013) Prediction and assessment of responses to renal artery revascularization with dynamic contrast-enhanced magnetic resonance imaging: a pilot study. Am J Physiol Renal Physiol 305:F672–F678. doi:10.​1152/​ajprenal.​00007.​2013 CrossRefPubMed
11.
Zurück zum Zitat Chen Y, Huang J, Xia L et al (2013) Monitoring laparoscopic radiofrequency renal lesions in real time using contrast-enhanced ultrasonography: an open-label, randomized, comparative pilot trial. J Endourol 27:697–704. doi:10.1089/end.2012.0694 CrossRefPubMed Chen Y, Huang J, Xia L et al (2013) Monitoring laparoscopic radiofrequency renal lesions in real time using contrast-enhanced ultrasonography: an open-label, randomized, comparative pilot trial. J Endourol 27:697–704. doi:10.​1089/​end.​2012.​0694 CrossRefPubMed
15.
Zurück zum Zitat Ma F, Cang Y, Zhao B et al (2012) Contrast-enhanced ultrasound with SonoVue could accurately assess the renal microvascular perfusion in diabetic kidney damage. Nephrol Dial Transplant 27:2891–2898. doi:10.1093/ndt/gfr789 CrossRefPubMed Ma F, Cang Y, Zhao B et al (2012) Contrast-enhanced ultrasound with SonoVue could accurately assess the renal microvascular perfusion in diabetic kidney damage. Nephrol Dial Transplant 27:2891–2898. doi:10.​1093/​ndt/​gfr789 CrossRefPubMed
19.
21.
Zurück zum Zitat Petrica L, Vlad A, Gluhovschi G et al (2015) Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study. J Diabetes Complications 29:230–237. doi:10.1016/j.jdiacomp.2014.11.014 CrossRefPubMed Petrica L, Vlad A, Gluhovschi G et al (2015) Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study. J Diabetes Complications 29:230–237. doi:10.​1016/​j.​jdiacomp.​2014.​11.​014 CrossRefPubMed
23.
Zurück zum Zitat Mackinnon B, Shakerdi L, Deighan CJ, Fox JG, O’Reilly DS, Boulton-Jones M (2003) Urinary transferrin, high molecular weight proteinuria and the progression of renal disease. Clin Nephrol 59:252–258. doi:10.5414/CNP59252 CrossRefPubMed Mackinnon B, Shakerdi L, Deighan CJ, Fox JG, O’Reilly DS, Boulton-Jones M (2003) Urinary transferrin, high molecular weight proteinuria and the progression of renal disease. Clin Nephrol 59:252–258. doi:10.​5414/​CNP59252 CrossRefPubMed
26.
Zurück zum Zitat Tanaka K, Hara S, Kushiyama A et al (2011) Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia. Clin Exp Nephrol. 15:391–397. doi:10.1007/s10157-011-0420-6 CrossRefPubMed Tanaka K, Hara S, Kushiyama A et al (2011) Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia. Clin Exp Nephrol. 15:391–397. doi:10.​1007/​s10157-011-0420-6 CrossRefPubMed
28.
Zurück zum Zitat Choi YJ, Yoon Y, Lee KY et al (2014) Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. FASEB J 28:3197–3204. doi:10.1096/fj.13-247148 CrossRefPubMed Choi YJ, Yoon Y, Lee KY et al (2014) Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. FASEB J 28:3197–3204. doi:10.​1096/​fj.​13-247148 CrossRefPubMed
Metadaten
Titel
Diagnostic value of quantitative contrast-enhanced ultrasound (CEUS) for early detection of renal hyperperfusion in diabetic kidney disease
verfasst von
Ling Wang
Jian Wu
Jia-Fen Cheng
Xin-Ying Liu
Fang Ma
Le-Hang Guo
Jun-Mei Xu
Tianfu Wu
Chandra Mohan
Ai Peng
Hui-Xiong Xu
Ya-Xiang Song
Publikationsdatum
01.12.2015
Verlag
Springer International Publishing
Erschienen in
Journal of Nephrology / Ausgabe 6/2015
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-015-0183-3

Weitere Artikel der Ausgabe 6/2015

Journal of Nephrology 6/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.